A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND)
2004 ◽
Vol 45
(2)
◽
pp. 617
◽
2015 ◽
Vol 29
(4)
◽
pp. 270-273
◽
Keyword(s):
2010 ◽
Vol 41
(1)
◽
pp. 26-30
◽
Keyword(s):
2019 ◽
Vol 5
(1)
◽
Keyword(s):